Sai Life Sciences Ltd.
1,259.00+21.0 (+1.70%)
3 Jul, 2:59 PM
Income Statement
Abridged
Understanding Income Statement
Sai Life Sciences Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
Balance Sheet
Abridged
Understanding Balance Sheet
Sai Life Sciences Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
Cash Flow
Abridged
Understanding Cash Flow Statement
Sai Life Sciences Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
Business Segment Analysis
FY End:
Mar 25
Sai Life Sciences Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.
Capex
Contract research, development and manufacturing (100.0%)₹ 369.28 Cr
Revenue / Sales
Contract research, development and manufacturing (100.0%)₹ 1,694.57 Cr
Assets
Contract research, development and manufacturing (100.0%)₹ 3,159.97 Cr
Operating Income
Contract research, development and manufacturing (100.0%)₹ 270.62 Cr
Regional Segment Analysis
FY End:
Mar 25
Sai Life Sciences Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.
Revenue / Sales
Outside India (98.7%)₹ 1,639.36 CrIndia (1.3%)₹ 21.03 Cr
Historical Segment Analysis
Track how Sai Life Sciences Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.
Business
Frequently Asked Questions
What is the revenue of Sai Life Sciences Ltd.?
The latest trailing twelve month revenue of Sai Life Sciences Ltd. is ₹ 2,192.49 Cr, reflecting a 1-year growth of 29.38% and a 3-year CAGR of 21.67%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Sai Life Sciences Ltd.?
The latest trailing twelve month net profit (PAT) of Sai Life Sciences Ltd. is ₹ 348.91 Cr, with a 3-year earnings CAGR of 224.62%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Sai Life Sciences Ltd.?
The trailing twelve month EBITDA of Sai Life Sciences Ltd. is approximately ₹ 464.30 Cr (based on an operating margin of 21.18%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Sai Life Sciences Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Sai Life Sciences Ltd. is 16.43. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Sai Life Sciences Ltd.?
The debt-to-equity ratio of Sai Life Sciences Ltd. stands at 0.12. The interest coverage ratio is 11.83x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Sai Life Sciences Ltd.?
The estimated book value per share of Sai Life Sciences Ltd. is 118.98 (derived from a P/B ratio of 10.58 and market price of ₹ 1,259.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Sai Life Sciences Ltd.?
The trailing twelve month operating cash flow of Sai Life Sciences Ltd. is ₹ 497.61 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Sai Life Sciences Ltd. report consolidated or standalone financials?
Sai Life Sciences Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.